Cargando…

Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes

BACKGROUND: The severity of the metabolic syndrome (MetS) is significantly associated with future coronary heart disease (CHD) among individuals without baseline Type 2 diabetes. However, the validity of assessing MetS severity among individuals with diabetes is unknown. OBJECTIVE: To assess for dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurka, Matthew J., Guo, Yi, Filipp, Stephanie L., DeBoer, Mark D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775549/ https://www.ncbi.nlm.nih.gov/pubmed/29351794 http://dx.doi.org/10.1186/s12933-017-0647-y

Ejemplares similares

SUN-064 Associations of a Metabolic Syndrome Severity Score with Future Coronary Heart Disease (CHD) and Diabetes in Fasting vs. Non-Fasting Individuals
por: DeBoer, Mark, et al.
Publicado: (2019)

Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program
por: DeBoer, Mark D., et al.
Publicado: (2018)

Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults
por: Gurka, Matthew J., et al.
Publicado: (2018)

Low sensitivity of the metabolic syndrome to identify adolescents with impaired glucose tolerance: an analysis of NHANES 1999–2010
por: DeBoer, Mark D, et al.
Publicado: (2014)

Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores
por: Gurka, Matthew J., et al.
Publicado: (2018)

Inter-relationships between the Severity of Metabolic Syndrome, Insulin and Adiponectin and their Relationship to Future Type 2 Diabetes and Cardiovascular Disease
por: DeBoer, Mark D., et al.
Publicado: (2016)

Clinical utility of metabolic syndrome severity scores: considerations for practitioners
por: DeBoer, Mark D, et al.
Publicado: (2017)

Progression of Metabolic Syndrome Severity During the Menopausal Transition
por: Gurka, Matthew J., et al.
Publicado: (2016)

MON-673 Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-Alcoholic Steatohepatitis
por: DeBoer, Mark Daniel, et al.
Publicado: (2020)

Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study
por: Guo, Yi, et al.
Publicado: (2018)

A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences
por: Gurka, Matthew J, et al.
Publicado: (2012)

Diagnosis of the Metabolic Syndrome Is Associated With Disproportionately High Levels of High-Sensitivity C-Reactive Protein in Non–Hispanic Black Adolescents: An analysis of NHANES 1999–2008
por: DeBoer, Mark D., et al.
Publicado: (2011)

Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies
por: Bruggeman, Brittany S., et al.
Publicado: (2021)

Assessing and Managing the Metabolic Syndrome in Children and Adolescents
por: DeBoer, Mark D.
Publicado: (2019)

Genetic predisposition to type 2 diabetes is associated with severity of coronary artery disease in patients with acute coronary syndromes
por: Zheng, Qiwen, et al.
Publicado: (2019)

Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
por: Östlund Papadogeorgos, Nikolaos, et al.
Publicado: (2016)

Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome
por: Eubanks, Anthony, et al.
Publicado: (2012)

Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease
por: Campbell, Duncan J, et al.
Publicado: (2011)

Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study
por: Opstad, Trine B, et al.
Publicado: (2011)

Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines
por: Kim, Jong-Youn, et al.
Publicado: (2013)

Associations of coronary artery calcified plaque density with mortality in type 2 diabetes: the Diabetes Heart Study
por: Raffield, Laura M., et al.
Publicado: (2018)

Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes
por: Lu, Tianyuan, et al.
Publicado: (2020)

A 19-SNP coronary heart disease gene score profile in subjects with type 2 diabetes: the coronary heart disease risk in type 2 diabetes (CoRDia study) study baseline characteristics
por: Beaney, Katherine E., et al.
Publicado: (2016)

Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes
por: Tong, Guoxin, et al.
Publicado: (2013)

Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease
por: Andersson, Charlotte, et al.
Publicado: (2010)

Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
por: Su, Gong, et al.
Publicado: (2011)

Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study
por: Krämer, Heike U, et al.
Publicado: (2012)

Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study
por: Venuraju, Shreenidhi M., et al.
Publicado: (2019)

Elevated resting heart rate is associated with the metabolic syndrome
por: Rogowski, Ori, et al.
Publicado: (2009)

Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery
por: Ram, Eilon, et al.
Publicado: (2020)

Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)
por: Leibovitz, Eyal, et al.
Publicado: (2013)

Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes
por: Fontes-Carvalho, Ricardo, et al.
Publicado: (2015)

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Groenewegen, Amy, et al.
Publicado: (2021)

Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study
por: Raffield, Laura M, et al.
Publicado: (2013)

The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender
por: Hyvärinen, Marjukka, et al.
Publicado: (2009)

Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study
por: Huth, Cornelia, et al.
Publicado: (2020)

Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease
por: Vonbank, Alexander, et al.
Publicado: (2013)

Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
por: Ma, Xiaoteng, et al.
Publicado: (2020)

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
por: Li, Yan-Rong, et al.
Publicado: (2018)

Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans
por: Kim, Lee Kyung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8krjjph72m783489m0bairq7jt